Vascular Inflammation in Psoriasis - Extension Study
Phase of Trial: Phase IV
Latest Information Update: 28 May 2018
Price : $35 *
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Biomarker; Pharmacodynamics
- Acronyms VIP-E
- 31 Aug 2018 Biomarkers information updated
- 14 Jun 2017 Status changed from active, no longer recruiting to completed.
- 11 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.